核苷类似物与干扰素对慢性乙肝的治疗效果及患者心理状态影响

Therapeutic effect of nucleoside analogues and interferon on chronic hepatitis B and psychological state of patients

ES评分 0

DOI
刊名
Journal of International Psychiatry
年,卷(期) 2022, 49(1)
作者
作者单位

河南省濮阳市人民医院感染性疾病科 ;

摘要
[摘要] 目的:分析慢性乙肝(CHB)患者接受核苷类似物(NAs)与干扰素(IFN)治疗的效果及对患者心理状态的影响。方法:将2019年1月—2019年12月接诊且行IFN治疗的40例CHB患者作为对照组,将同期接诊且行NAs+IFN治疗的40例CHB患者作为观察组,对组间心理状态、肝纤维化指标、谷丙转氨酶(ALT)复常率、HBV-DNA不可测率、HBV抗原展开分析。结果:(1)组间心理状态、肝纤维化指标在治疗前无明显差异,P>0.05;观察组心理状态、肝纤维化指标在治疗后优于对照组,P<0.05;(2)观察组治疗1、3、6、12个月时的ALT复常率、HBV-DNA不可测率均高于对照组,P<0.05;(3)治疗12个月后,观察组HBV抗原检测结果优于对照组,P<0.05。结论:对CHB患者行NAs+IFN治疗,可以增强疗效,促进ALT复常,改善患者肝功能及心理状态,值得推广。
Abstract
[Abstract] Objective: to analyze the effect of nucleoside analogues (NAS) and interferon (IFN) on the psychological status of patients with chronic hepatitis B (CHB). Methods: 40 CHB patients who received IFN treatment from January 2019 to December 2019 were selected as the control group, and 40 CHB patients who received NAS + IFN treatment at the same time were selected as the observation group. Results: (1) There was no significant difference in mental state and liver fibrosis indexes between the two groups before treatment, P>0.05; mental state and liver fibrosis indexes of the observation group were better than those of the control group after treatment, P<0.05; (2) ALT normalization rate and HBV-DNA undetectable rate of the observation group after 1, 3, 6 and 12 months of treatment were higher than those of the control group, P<0.05; (3) HBV antigen detection results of the observation group after 12 months of treatment were excellent Compared with the control group, P<0.05. Conclusion: the treatment of NAS + IFN for CHB patients can enhance the curative effect, promote the normalization of alt, improve the liver function and mental state of patients, which is worthy of promotion.
关键词
关键词:核苷类似物;干扰素;慢性乙肝;治疗效果;心理状态
KeyWord
Key words: nucleoside analogues; interferon; chronic hepatitis B; therapeutic effect; psychological state
基金项目
页码 141-144
  • 参考文献
  • 相关文献
  • 引用本文

胡瑞华*. 核苷类似物与干扰素对慢性乙肝的治疗效果及患者心理状态影响 [J]. 国际精神病学杂志. 2022; 49; (1). 141 - 144.

  • 文献评论

相关学者

相关机构